Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31535954 | 0.79 | ADRA1D (0.41) | CA4 | |
| SCHEMBL31605594 | 0.73 | FAAH (0.38) | CA4 | |
| SCHEMBL31120831 | 0.71 | KAT7 (0.40) | CA4 | |
| SCHEMBL31605546 | 0.71 | CA1 (0.37) | CA4 | |
| Trifluoroacetic Acid SCHEMBL31605629 | 0.70 | F10 (0.33) | CA4 | |
| SCHEMBL31605582 | 0.69 | KAT7 (0.37) | CA4 | |
| SCHEMBL31605588 | 0.68 | CA4 (0.35) | CA4 | |
| SCHEMBL31605595 | 0.67 | KAT7 (0.49) | — | |
| SCHEMBL31605584 | 0.67 | CA4 (0.35) | CA4 | |
| SCHEMBL31605638 | 0.66 | CA4 (0.36) | CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122182-A1 | MYST Inhibitors | Isosterix, Inc. | 2025-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122182-A1 | MYST Inhibitors | MNAT1, SUGT1, ACAT2 | CA4 4560/4885LOXL2 1775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.